Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–4 of 4 matching trials from the live ClinicalTrials.gov search.
Filters: Intervention: IBI-10090 Clear all
Terminated Phase 2 Interventional Results available

Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients

NCT01214174
View directory record Official record
Conditions
Ocular Inflammation
Interventions
IBI-10090
Drug
Lead sponsor
ICON Bioscience Inc
Industry
Eligibility
40 Years and older
Enrollment
42 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2012
U.S. locations
1
States / cities
Eugene, Oregon
Source: ClinicalTrials.gov public record
Updated Sep 18, 2013 · Synced Oct 23, 2026, 4:00 PM EDT
Completed Phase 2 Interventional Results available

Efficacy and Safety of IBI-10090 in Ocular Surgery Patients

NCT01606735
View directory record Official record
Conditions
Inflammation Associated With Cataract Surgery
Interventions
IBI-10090
Drug
Lead sponsor
ICON Bioscience Inc
Industry
Eligibility
40 Years and older
Enrollment
172 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2013
U.S. locations
2
States / cities
Hemet, California • Temecula, California
Source: ClinicalTrials.gov public record
Updated Sep 22, 2014 · Synced Oct 23, 2026, 4:00 PM EDT
Completed Phase 3 Interventional Results available

The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery

NCT02006888
View directory record Official record
Conditions
Inflammation, Cataracts
Interventions
IBI-10090, Placebo
Drug
Lead sponsor
ICON Bioscience Inc
Industry
Eligibility
40 Years and older
Enrollment
394 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014
U.S. locations
1
States / cities
Lancaster, California
Source: ClinicalTrials.gov public record
Updated Apr 23, 2018 · Synced Oct 23, 2026, 4:00 PM EDT
Terminated Phase 2 Interventional Results available

Efficacy and Safety Study of IBI-10090 in Patients Undergoing Cataract Surgery

NCT01048593
View directory record Official record
Conditions
Inflammatory Reaction Due to Ocular Lens Prosthesis
Interventions
IBI-10090
Drug
Lead sponsor
ICON Bioscience Inc
Industry
Eligibility
40 Years and older
Enrollment
6 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010
U.S. locations
1
States / cities
Los Altos, California
Source: ClinicalTrials.gov public record
Updated Dec 4, 2018 · Synced Oct 23, 2026, 4:00 PM EDT